Published procurement activity · 99 tenders
Buyer information published with procurement notices.
SNEE ICB are commissioning Care Home placements on a spot purchase basis for patients that are assessed to qualify for Continuing Healthcare funding. This includes fast track and urgent placements.
The ICB is seeking to appoint an existing provider of primary medical care services already located within a five-mile radius of the Bluebell Surgery premises within the SNEE ICB area for the patient list registered with Bluebell Surgery, Jack Andrews Drive, Highwoods, Colchester, Essex, CO4 9YN. The practice is currently manage
SNEE ICB are commissioning Care Home placements on a spot purchase basis for patients that are assessed to qualify for Continuing Healthcare funding. This includes fast track and urgent placements.
SNEE ICB are commissioning Care Home placements on a spot purchase basis for patients that are assessed to qualify for Continuing Healthcare funding. This includes fast track and urgent placements.
SNEE ICB are commissioning Care Home placements on a spot purchase basis for patients that are assessed to qualify for Continuing Healthcare funding. This includes fast track and urgent placements.
SNEE ICB are commissioning Care Home placements on a spot purchase basis for patients that are assessed to qualify for Continuing Healthcare funding. This includes fast track and urgent placements.
SNEE ICB, in collaboration with ESNEFT and local weight management providers and commissioners across the Integrated Care System (ICS), propose the creation of a Single Point of Access (SPoA) for all ICS weight management referrals. This is currently across the SNEE geography but is subject to change given future ICB changes, an
SNEE ICB are commissioning Care Home placements on a spot purchase basis for patients that are assessed to qualify for Continuing Healthcare funding. This includes fast track and urgent placements.
Level 2b Residential Neurological Rehabilitation Service provides rehabilitation for people with more complex neurological disease or injury. This centres around enabling people to achieve optimal functional levels, managing residual impairments of neurological damage and achieving the best possible quality of life within their
As part of the allocation for 2025/26 planning, the ICB received Revenue Incentive funding of £8.0 million. This funding is being transferred to ESNEFT on a non-recurrent basis for 2025-2026 only.
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.